Translational Drug Development (TD2)

0 followers


Translational Drug Development (TD2) is an oncology-focused Contract Research Organization (CRO) that supports improved and accelerated development of medicines for life-threatening diseases. We help companies move their drugs through the critical stages of preclinical, regulatory and clinical trial... Read more

Industries

Headquarters

Employees

Links

Org chart

Stephen Gately

Collapse
Susan Night
Sr. Vice President, Strategy And Growth
Alan Miller M.D.
Chief Medical Officer
Shawnna Rustenbeck
Vice President Of Finance And Operations
Kristen Dempsey
Senior Vice President Commercial Development
Jennifer Vergara
Senior Director, Clinical Data Services